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 new experimental technique for obtaining diagnostic test systems is introduced based on conjugates 
"polymer microsphere–bioligand" for rapid diagnosis of autoantibodies to the modified protein on example of 
thyroglobulin, which consists of preliminary blocking of aldehyde groups of polymer microspheres by glycine 
amine groups, and then of the covalent interaction between carboxyl group of glycine and the amino groups of 
thyroglobulin. This way of creating test systems has enhanced the sensitivity of the reaction of latex agglutination 
(RLA) by extending the boundaries of titer. 
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Introduction 
A promising approach to improve the pre-
ventative and drug treatment is early diagnosis of 
multifactorial proteopathies underlying social di-
seases. Such diseases include autoimmune thyroid 
disease (Hashimoto's thyroiditis, Graves' disease 
and other) 1–3, due to disruption of the structure 
of thyroglobulin (proteopathy), leading to its 
accumulation and antigenic effects on the body. 
Development of modern highly sensitive diag-
nostic test systems that can detect autoantibodies to 
thyroglobulin can be an important criterion for immuno-
logical diagnosis of autoimmune thyroid diseases. 
Among a variety of laboratory diagnostic me-
thods (radioimmunoassay RIA) [4], enzyme-linked 
immunosorbent assay (ELISA) [5], immunochro-
matographic assay (IHA) [6], etc., a special place 
in immunodiagnostic practice takes the reaction of 
latex agglutination (RLA) [7–9]. This is the easiest 
screening method of testing which belongs to the 
category of qualitative or semi-quantitative me-
thods of analysis. The relative cheapness of ana-
lysis, high sensitivity, specificity, and reproduci-
bility of the RLA method, simplicity and the ability 
to test in almost any conditions allow for rapid 
diagnosis of diseases, both in single and in mass trials. 
RLA tests are based on a visual assessment of 
the nature of agglutination "clumping" of polymer 
particles containing specific surface bioligands 
(antibodies or antigens) that can bind to a de-
tectable affinity component (antigen-antibody). 
The purpose of this study was to develop me-
thodological bases for the construction of highly 
sensitive test systems based on conjugates "poly-
mer microsphere-bioligand" for rapid laboratory 
diagnosis of autoantibodies to thyroglobulin 





Styrene, purified from the stabilizer with 5% 
aqueous sodium hydroxide solution, washed with 
water until neutral, dried over calcined calcium 
chloride and twice distilled in a vacuum. The 
fraction boiling at 41°C (2.1 kPa) was used, d420 = 
0.906 g/cm3. Mass fraction is of 99% of the main 
substance. 
Styrene sulfonate sodium, мass fraction is of 
99% of the main substance. 
Acrolein, a technical product of «Fluka», three 
times distilled at atmospheric pressure. The fraction 
boiling at 52°C was used, d420 = 0.806 g/cm3. 
Azobisisobutyronitrile — initiator, was purified 
by recrystallization from methanol. The melting 
point is 101C. 
Potassium persulfate — initiator, without 
further purification. Mass fraction is of 99% of the 
main substance. 
Polyvinylpyrrolidone, applied with a molecular 
weight of 40,000, used the mark "reagent grade" 
without further purification. 
(N-Ethyl-N'-(3-dimethylaminopropyl) carbodiimi-
de hydrochloride) — «Merck» company. Purity — 98%. 
Thyroglobulin — was obtained at the 
Mechnikov Research Institute of Vaccines and 
Sera, the molecular weight of 600 kDa. Purity is 
not less than 98%. 
Serum samples of patients with diseases of the 
thyroid gland against thyroglobulin (titer immu-
nosorbent assay (ELISA) — 1:3240) were obtained 
from the Diagnostic Center Mechnikov Research 
Institute of Vaccines and Sera. 
Phosphate-buffered saline (pH 7.2), prepared 
by mixing 720 mL of the solution (11.876 g) 
Na2HPO4 in 1000 mL of distilled water and 280 
A 
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mL (9.078 g), КH2PO4 in 1000 mL of distilled 
water to the total volume of the solution phosphate 
salts (1000 mL), 9 g NaCl. Water - bidistillate. 
 
Methods 
Seed polymerization method 
A seed polymerization of the monomers 
(acrolein, styrene) was performed in 1.5 L reactor. 
The reactor is charged bare polystyrene suspension 
injected stabilizers (styrenesulfonate sodium and 
polyvinylpyrrolidone) and distilled water. Degas-
sing of the reaction mixture in the reactor was 
carried out by a nitrogen purge 200–250 rpm 
stirring for 5–10 minutes. In parallel, an oil-soluble 
initiator dissolved (azobisisobutyronitrile) in the 
monomer, and injected into the reactor. Conduct 
degassing the reaction mixture with stirring, as 
described above, for 15–20 minutes. 
First there is swelling of polystyrene seed 
particles in the reaction mixture containing mono-
mer, at room temperature (20±0.5C) for 24 h. The 
reactor was connected to the thermostat, the 
temperature was adjusted to 70±0.5C and intersect 
the start of polymerization. 3 hours after the start of 
the polymerization initiator is introduced additional 
potassium persulfate dissolved in distilled water. 
The polymerization was carried out at a tem-
perature of 70±0.5C at stirring 200–250 rpm to 
complete monomer conversion. For the control of 
monomer conversion in the suspension samples 
from the reactor was carried out every 2 h. After 24 
h, the polymerization is stopped. 
Cleaning polymer suspensions of residual 
components of the polymerization 
Cleaning polymer slurry method is carried out 
using micro filtration cell. To clean the polymer 
slurry used 3 cell filtration capacity of 1 liter. In 
each cell using a funnel and a measuring cylinder 
filled polymer suspension was added distilled water 
and mixing included. 
Microfiltration was carried out at a pressure of 
117–137 kPa, using the compressor. Particles 
polymer slurry, which are on the filter membrane 
of the cell, add distilled water and filtered, spent 2 
more times. After filtering the contents of 3 
filtration cells were fused into the tank for the 
treated slurry and solids content was determined in 
the resulting polymer slurry. 
Polymer suspension handed to the stage of the 
depolimerisation by γ-radiation beams (for 6 hours, 
the dose rate of 100 rad/s).  
Aggregate stability of polymeric microsphe-
res in a buffer solution (phosphate-buffered 
saline (pH 7.2)) was determined using light and 
electron microscopes, and deposition in the wells of 
96-well microplates (firms «Lenmed Polimer», 
Russia, «Greiner», Germany). 
Determination of aggregate stability of the 
particles in the wells of 96-well plates was 
performed by the following procedure: 
The first row is contributed to 25 mL of buffer 
solution. Prepared 4% albumin solution in a buffer 
solution and measured it at 25 mL in the first row 
microplates, the concentration of albumin in the 
first hole is equal to 2% of the first series of wells 
in the next two steps (reducing the concentration of 
albumin 2-fold) was performed breeding albumin, 
leaving only the last row with a buffer solution (as 
zero control). 
4% → 2 → 1 → 0.5 → 0.25 → 0.125 → 0.06 
→ 0.03 → 0.015 → 0.008 → 0.004 → 0.002% 
Next to all the wells of row added to 25 mL 
0.3% strength polymer slurry plate was shaken and 
left at room temperature for 5–6 hours. After 6–7 
hours (time of sedimentation of particles of 
polymer slurry) on the bottom of the wells formed 
precipitate point in aggregate stability of particles, 
the particles of aggregate instability agglutinates 
formed in an inverted umbrella. The minimum 
concentration of albumin, in which there is no 
aggregation of particles, is determined by the final 
hole with a point precipitate. 
Detection of autoantibodies to thyroglobulin 
(Tg) immunoassay (ELISA) 
Antibodies to Tg were determined by indirect 
ELISA using polystyrene plates sensitized with 
highly purified preparation Tg (purification of at 
least 98%). Since antibodies to Tg belong mainly to 
the IgG class (95%), it was used as a conjugate of 
protein A labeled with horseradish peroxidase. The 
reaction showed a mixture of substrate tetrame-
thylbenzidine («Clinical Science Products Inc», 
USA). Tg antibody levels were evaluated using the 
calibration curve. To take account of the reaction 
was carried out on a multi-channel photometer 
«Anthos» (Austria) at a wavelength of 450 nm. 
Detection of thyroglobulin (Tg) 
immunoassay (ELISA) 
Tg taped a "sandwich" ELISA: the surface of 
the wells of polystyrene plates sorbed affinity 
isolated rabbit polyclonal antibodies to thyro-
globulin. Formed in the first step of the reaction 
complex "thyroglobulin autoantibody" identified 
conjugate antibody Tg-labeled horseradish peroxi-
dase. Tg concentration in the samples was calcu-
lated from the calibration curve of the optical 
density on the concentration of triglycerides in the 
calibration samples. Sensitivity is not less than 3 
ng/mL, accuracy — 90-100%, range of detectable 
concentrations — 5–500ng/mL. 
Covalent binding of functional groups 
bioligands with functional groups of the polymer 
Covalent binding bioligands with carboxyl 
groups located on the surface of polymer micro-
spheres was as follows: after centrifugation poly-
mer suspension was transferred to phosphate-
buffered saline (pH 7.2) and adjusted to the 
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concentration of the polymer slurry to 0.5%. 1 mL 
of 0.5% of the second suspension was mixed with a 
solution of 1 mL of carbodiimide, the concentration 
of which was equal to 0.1 mg/mL. After incubation 
for 30 min at room temperature, it was washed 
three times with the suspension of unreacted 
carbodiimide phosphate buffer (pH 7.2) and con-
ducted three times by centrifugation for 15 min at 
4000 rpm. Polymer slurry with particles contained 
on the surface, activated carboxyl groups of the 
polymer, mixed with an equal volume of solution 
bioligands (various concentrations), taken in 2 mL. 
After incubation for 4–6 hours at a temperature of 
+37C are not connected bioligands washed by 
centrifuging the solution three times for 15 min. at 
4000 rpm, and diluted with phosphate buffer (pH 
7.2), slurry concentration of 0.1%. 
Reaction of latex agglutination (RLA) was 
performed in 96-well microplates 
Quantitative determination of the detected 
component (antibody/antigen). Additions to the 
wells of 96-well polystyrene plates were carried out 
according to the scheme shown in Table 1. 
 
Table 1. Addition to the wells 
 1 2 3 4 5 6 7 8 9 10 11 12 Dilution 
A NC PC С1 С2 С3 С4 С5 С6 С7 С8 С9 С10 1:10 
B NC-1 PC-1 С1-1          1:20 
C NC-2 PC-2 С1-2          1:40 
D NC-3 PC-3 С1-3          1:80 
E NC-4 PC-4 С1-4          1:160 
F NC-5 PC-5 С1-5          1:320 
G NC-6 PC-6 С1-6          1:640 
H NC-7 PC-7 С1-7          1:1280 
 
1. As well A1 contributed 50 ul serum negative 
control (NC). NK-serum containing no antibo-
dy/antigen. 
2. As well A2 contributed 50 ul of serum with 
the positive control (PC). PC serum containing 
antibodies/antigens. 
3. To wells A3–A12 was introduced into 50 
mL test sera (C1–C10) in a 1:10 dilution in 
accordance with Table 1. 
4. Into the wells of rows B to H was introduced into 
25 mL phosphate-buffered saline (0.01 M, pH = 7.4). 
5. From the first of row A (at 25 mL) in the 
next series of wells B  C  D  E  F  G  
H (for disposal) in increments of 2 (2-fold dilution) 
was performed dilution solutions. 
6. To each well of the plate was introduced into 
25 mL 0.3% suspension (diagnostic test kits), the 
plate was shaken and left at room temperature for 
1.5–2 h. 
With positive RLA is formed at the bottom of 
the wells in the agglutinates inverted umbrella with 
a negative - point precipitate. 
In the analysis of the studied serum their 
maximum dilution giving a positive reaction is taken.  
Under a positive reaction in a dilution of sera 
studied understand the value of credits in two or 
more times the value of credits in the negative 
control serum (NC). 
The lowest concentration tested agglutinate 
determined by the final hole with a positive 
(agglutination unit (AU)). The next hole, which is 
not observed RLA is called — (sub agglutination 
unit (SU)). 
Determination of particle size and particle size 
distribution were determined by photon – corre-
lation spectroscopy on the device «Malvern» (Eng-
land) [10]; the concentration of aldehyde groups on 
the surface of the polymer microspheres were 
determined by conductometric titration [11]; the 
protein concentration was determined by the Lowry 
method [12]; for determination of the monomer 
was carried out by spectrophotometry [13]. 
Results and Discussion 
General technology of creating diagnostic test 
kits based on conjugates "polymer microsphere-
bioligands" includes the following process steps 
(Fig. 1). 
The first stage of the technological process 
(TP.1) — synthesis of functional polymeric 
suspensions with a narrow particle size distribution, 
stable with immobilized specific bioligands. 
The second stage of the process (TP.2) is to 
clean polymer suspensions of residual impurities 
(monomer, initiator, stabilizer, etc.) capable of 
interacting with a detectable component, which 
negatively affects the registration and conduct of 
immunochemical RLA. 
The third and fourth stages of the process are 
the most labor-intensive and consist of isolation 
and purification of specific bioligands (TP.3), and 
selection of the conditions of immobilization of 
bioligands on the surface of particles of the 
polymer suspension (TP.4). 
On the first (TP.1) and second (TP.2) stages of 
the process polymer suspension was obtained with 
particles used as carriers of bioligands (Tg) in the 
development of test systems for the detection of 
autoantibodies to thyroglobulin by the RLA method 
(Fig. 2). 
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Preparing the equipment for launching and purging with nitrogen 
  
TP.1 Synthesis of polymer suspensions TP.3 
 
Isolation and purification 
bioligands 
  
TP.2 Cleaning of polymer suspensions 
  
TP.4 Immobilization of bioligands on the surface of polymer microspheres and purification 
  
Packing, packaging, labeling of diagnostic test kits 












Fig. 2. Microphotograph of polymeric microspheres and a histogram of particle size distribution.  
Average diameter — 4.1 micrometer. 
 
Polymer particles had an average diameter of 
microspheres - 4.1 microns, was characterized by a 
narrow particle size distribution (coefficient of 
variation less than 3%), and contained aldehyde 
groups on the surface at 1.2*10-3mol/g of polymer 
[11]. Mass fraction of residual monomer is no more 
than 0.05%. Particles retained aggregate stability in 
0.25 M solution of NaCl. The polymer content of 
the suspension was 0.4% (dry residue). 
Synthesized polymer microspheres met the 
requirements for the carriers of bioligands required 
to construct on their basis diagnostic test systems, 
namely: 
• were characterized by a narrow particle size 
distribution, which allows to accurately determine 
the surface area of the carrier and determine the 
extent of its coverage by bioligands, which in turn 
causes the similar nature of their behavior during 
the reaction of latex agglutination (RLA); 
• contained functional groups (aldehyde 
groups) on the surface of polymer microspheres 
needed to interact with amino groups of bioligands; 
• had aggregate stability in buffer (phosphate-
buffered saline pH 7.2) and in biological solution 
(serum) which prevents non-specific aggregation of 
particles; 
• had a high rate of sedimentation in the wells 
of 96–well microplates (30–40 min), which allows 
for express testing; 
• did not contain residual components of 
polymerization (monomer, initiator, surfactant, 
etc.) that affect the immobilization of bioligands on 
the surface of the polymer particles, and the 
stability of test systems for storage. 
In the third stage of the process (TP.3) were 
obtained molecules of specific bioligand (Tg), 
which was isolated from the supernatant by 
ultracentrifugation of homogenate thyroid tissue. 
Pure thyroglobulin was isolated by gel filtration on 
a column of Sepharose 6B. Elution of thyroglobulin 
was performed in 0.01 M phosphate buffer pH 7.2–
7.4. First collected fraction (peak 1) was 
concentrated by ultrafiltration using membranes 
«Amicon» Brand X-300. The degree of purification 
of thyroglobulin was controlled by electrophoresis 
in 5% polyacrylamide gel. Thyroglobulin is a dimer 
with a molecular weight of 600000 Da. The degree 
of purification of thyroglobulin was 98%. 
The fourth stage of the process (TP.4) is the 
most high-tech process. The difficulty lies in the 
fact that, in each case it is needed to immobilize 
bioligands of different nature, size, molecular 
weight, etc. (viruses, antigens, antibodies, hormo-
nes, etc.) on the surface of polymer microspheres. 
This is largely due to the lack of systematic 
research to identify the factors, that allow the 
native conformation of bioligands when immo-
bilized on the surface of polymer microspheres and, 
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therefore, to provide high sensitivity of RLA. 
To study the immobilization of thyroglobulin 
(three-dimensional structure of which it is currently 
unknown) on the surface of polymer microspheres 
a computer model of its site was constructed 
homologous to acetyl cholinesterase, which clearly 
shows the location of the amino groups of lysine 
residues (Lys), and half of the known determinants 
of thyroglobulin recognized by autoantibodies [1, 
14] (Fig. 3, Table 2). 
 
Table 2. Name determinants and their amino acid 
length, which are located on thyroglobulin site 
homologous to acetyl cholinesterase 
№ Name of 
determinants Tg 
Length of amino acid 
residues  
1 M4-814 2188-2242 
2 TgP15 2339-2358 
3 2376-2464 2376-2464 
4 TgP26 2471-2490 
5 TgP41 2651-2670 
 
Fig. 3. A computer model of the site thyroglobulin homologous to acetyl cholinesterase. 
 
It is evident that the amino groups of lysine 
residues are concentrated in three places of biomo-
lecule, each of which can react with the aldehyde 
groups of polymeric microspheres, including those 
groups that are close to the sites of a determinant 
responsible for binding to the active sites of 
autoantibodies. 
The computer model allowed to assume that 
the interaction of amino groups contained in the 
residues Lys2764 and Lys2768 with aldehyde 
groups of polymeric microspheres, will not escape 
the antigenic determinants of thyroglobulin, and 
possible interactions of amino groups contained in 
the residues Lys2447, Lys2536, Lys2602, Lys2712, 
Lys2720 Lys2223 will lead to blocking them. 
To obtain conjugates "polymer microsphere-
thyroglobulin" covalent binding of amino groups of 
thyroglobulin was conducted with aldehyde groups 
present on the surface of polymer microspheres. 
The scheme of covalent interaction of aldehyde 
groups contained on the surface of polymer micro-
spheres (PM) with the amino groups of thyro-
globulin (Tg) is shown in Fig. 4. 
 
 
Fig. 4. Scheme of interaction of aldehyde groups contained on the surface of polymer microspheres (PM) 
with the amino groups of thyroglobulin (Tg). 
 
The interaction of amine and aldehyde groups 
result in Schiff base which is unstable at low pH, so 
it was reduced with sodium borohydride (tem-
perature 25°C, 30 min). 
It was found that in 3 hours at 37C 80% of 
thyroglobulin binds with the surface of the polymer 
from its original amount (500 µg/mL), and at 4C 
in 12–14 hours (Fig. 5). Further exposure does not 
increase the amount of bound thyroglobulin, due, 
apparently, to saturation of particle surface with 
protein molecules. The calculation of the concent-
ration of bound thyroglobulin with the surface of 
polymer microspheres were carried out on the basis 
of the determination of thyroglobulin in solution 
(Lowry method) before the immobilization process 
of thyroglobulin to the surface of the polymer, and 
after the cleaning process of the particles of the 
polymer suspension. 
But the reaction of latex agglutination (RLA) 
with the developed test system did not take place. 
Reducing the number of molecules of thyroglobulin 
in the interphase layer of polymer microspheres 
from 80% to 4% did not lead to the expected result. 
It was suggested that after the restoration of a 
Schiff base with sodium borohydride may occur 
decontamination of determinant sites of thyro-
globulin responsible for binding to the active sites 
of autoantibodies. Violation of the native confor-
mation of bioligands can occur as a result of a 
strong multi-point adsorption of Tg on the surface 
of polymer microspheres. 
 































Immobilization time on the surface 
of Tg polymer particles, an hour. 
 
Fig. 5. Effect of temperature on the rate of immobilization of thyroglobulin (Tg) on the surface  
of polymer microspheres (1 – at 4°C, 2 – at 20°C, 3 – at 37°C). 
 
It was proposed initially to block aldehyde 
groups of polymeric microspheres with amino 
glycine, which was used as a spacer, and then 
conduct a covalent interaction between the 
carboxyl groups of glycine and amino groups of 
thyroglobulin (Fig. 6). 
 
Fig. 6. Scheme of interaction between aldehyde groups contained on the surface of polymeric microspheres  
and amino groups of glycine with subsequent activation of its carboxyl groups by carbodiimide,  
and accession of the amino groups of thyroglobulin. 
 
Immobilization of glycine on the surface of 
polymer microspheres was performed from 
hydrochloric acid solution of glycine, taken in the 
concentration range of 0.1–1.0 M at different pH 
values from 3.0 to 5.0. 
Fig. 7 shows the change in the concentration of 
aldehyde groups on the surface of polymer 
microspheres on incubation time of polymeric 




















































Residence time of the polymer particles 
in 1M solution of glycine, an hour 
Fig. 7. Changing of the number of aldehyde groups on the surface of polymeric microspheres  
on the time of immersion in a solution of 1 M glycine. 
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From the data presented in Fig.7 we see that 
after exposure of the suspension for 1 hour at 37C 
the concentration of aldehyde groups decreased 2 
times, and when after exposing polymeric 
microspheres in a solution of glycine for 2 hours 
there is a complete blockage of glycine. 
Carboxyl groups of glycine on the surface of 
polymer microspheres, were activated by carb-
odiimide (N-ethyl-N'-(3-dimethylaminopropyl)-
carbodiimide hydrochloride) and attached amino 
groups of thyroglobulin to them to form peptide 
bond. In this case, the amount of spent thyro-
globulin was 8% of its original amount (500 
µg/mL). 
Created diagnostic test-systems "PM-glycine-
TG", using a spacer-glycine, provided clear diffe-
rences in testing serum samples with high 400-
1700 IU/mL (titer RLA - 1:640 and >), an average 
of 100-400 IU/mL (titer RLA - 1:80-1:640) and a 
low of 20-100 IU/mL (titer RLA - 1:10-1:80) 
content of autoantibodies to thyroglobulin. 
For the assessment of the sensitivity of test 
systems "PM-glycine-TG", a comparative analysis 
of the detection of autoantibodies to thyroglobulin 
by the RLA and the traditional methods of testing - 
enzyme immunoassay (ELISA), hemagglutination 
(using red blood cells) (IHA). 
Table 3 presents the results of detection of 
autoantibodies to thyroglobulin RLA different 
methods of analysis, ELISA and IHA. 
 
Table 3. The identification of autoantibodies to thyroglobulin methods RLA, ELISA and IHA 
Group surveyed Number of sera tested 





Number of sera matched with data RLA 
according to 
ELISA  according to IHA 
Donors 30 10–30 28 29 
Patients with 
autoimmune 
thyroid disease        
10 30–100 9 10 
30 100–400 27 28 
20 400–1000 19 19 
10 1000–1700 9 10 
Percentage of matches 92% 96% 
Note: for a negative result in RLA adopted titer autoantibodies thyroglobulin equal 1:10. 
 
Agreement of the results to identify autoanti-
bodies to thyroglobulin by RLA and by ELISA or 
IHA noted in 92% and 96%, respectively. Diffe-
rences are associated with both initial properties of 
used thyroglobulin from different manufacturers 
(the firm "Alcor-BIO" or obtained from Mechnikov 
Institute of Vaccines and Sera), and with the 
characteristics of the antigenic structure of 
thyroglobulin after its immobilization on a solid 
phase polymer plates (ELISA), or on the surface of 
biological media – erythrocyte (IHA) [15]. 
The above results led to the establishment of 
low-waste technology for the test of the "PM-
glycine-TG" with the use of polymer microspheres 
and thyroglobulin, meeting the requirements of 
their use in modern clinical and diagnostic 
laboratories in the identification of auto-antibodies 
to thyroglobulin thyroid cancer (see Report 2). 
Conclusion 
A new experimental technique for obtaining 
diagnostic test systems is introduced based on 
conjugates "polymer microsphere-bioligand" for 
rapid diagnosis of autoantibodies to the modified 
protein on example of thyroglobulin, which 
consists of preliminary blocking of aldehyde 
groups of polymer microspheres by glycine amine 
groups, and then of the covalent interaction 
between carboxyl group of glycine and the amino 
groups of thyroglobulin. This way of creating test 
systems has enhanced the sensitivity of the reaction 
of latex agglutination (RLA) with extension of the 
boundaries of titer. 
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